Showing results (201-210 of 346) with videos related to
Sort By:
Pageof 35
British Journal of Cancer|July 1, 1989
The use of granulocyte colony-stimulating factor to increase the intensity of treatment with doxorubicin in patients with advanced breast and ovarian cancerM H Bronchud, A Howell, D Crowther, et al.British Medical Journal|February 19, 1972
Adriamycin in the treatment of acute leukaemiaJ M Whitehouse, D Crowther, C J Bateman, et al.British Journal of Cancer|November 1, 1992
Glutathione S-transferase activity and isoenzyme distribution in ovarian tumour biopsies taken before or after cytotoxic chemotherapyD Murphy, A T McGown, A Hall, et al.Cancer|September 15, 1983
The effect of combination chemotherapy on ovarian function in women treated for Hodgkin's diseaseE Whitehead, S M Shalet, G Blackledge, et al.European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Recombinant human interleukin-4 (rhu IL-4) administered by the intravenous and subcutaneous routes in patients with advanced cancer--a phase I toxicity study and pharmacokinetic analysisJ Prendiville, N Thatcher, M Lind, et al.Cancer|February 1, 1982
The effects of Hodgkin's disease and combination chemotherapy on gonadal function in the adult maleE Whitehead, S M Shalet, G Blackledge, et al.British Journal of Cancer|July 4, 1998
High-dose therapy including carboplatin adjusted for renal function in patients with relapsed or refractory germ cell tumour: outcome and prognostic factorsM P Lyttelton, E S Newlands, C Giles, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1995
Secondary tumours following etoposide containing therapy for germ cell cancerC Boshoff, R H Begent, R T Oliver, et al.Bone Marrow Transplantation|July 1, 1994
Effects of erythropoietin on mobilisation of haemopoietic progenitor cellsR Pettengell, P J Woll, J Chang, et al.British Journal of Cancer|January 1, 1996
Towards quality control in cancer chemotherapyC Woodman, M Nicolson, L Hare, et al.Pageof 35